NEW YORK , March 18, 2013 /PRNewswire/ -- Affymax, Inc.
Lifshitz Law Firm announces that a class action suit was filed in the United States District Court for the Northern District of California , alleging that Affymax, Inc. ("Affymax" or the "Company") (AFFY) issued false and misleading statements to investors between December 8, 2011 and February 22, 2013 (the "Class Period") by failing to adequately disclose: (1) that the Company's FY 2012 financial guidance was materially overstated; (2) that reported sales of its primary drug product were not sustainable; and (3) that the defendants were materially overstating sales and understating the potential liabilities related to its primary drug product, including refunds and potential liability to injured patients.
Sign-up for Lifshitz Law Firm Announces Class Action Lawsuits against Affymax, Inc., Impax Laboratories Inc., and Tangoe, Inc. investment picks